Position in ABT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,124,405
-$69,972 QoQ
Shares Held
45,453
+11.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
3.00%
of 13F equity value
Holder Rank
#780
of 2,959 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LYNX CAPITAL GROUP LTD /ADV holds $4,748,600 across 2 Medical Devices names. ABT ranks #1 (86.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
45,453 | $4,124,405 | |
| 2 | BSX |
Boston Scientific Corp
|
14,625 | $624,195 |
All Filings in ABT
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,124,405 | 45,453 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,194,377 | 40,853 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $5,143,029 | 41,049 | Shares | Sole | 2026-08-12 | |
| 2025-09-30 | $3,355,063 | 25,049 | Shares | Sole | 2026-08-12 | |
| 2025-06-30 | $3,505,657 | 25,775 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $3,468,001 | 26,144 | Shares | Sole | 2026-08-12 | |
| 2024-12-31 | $2,364,225 | 20,902 | Shares | Sole | 2026-08-10 | |
| 2024-09-30 | $2,393,753 | 20,996 | Shares | Sole | 2026-08-10 | |
| 2024-06-30 | $2,161,535 | 20,802 | Shares | Sole | 2026-08-10 | |
| 2024-03-31 | $2,353,216 | 20,704 | Shares | Sole | 2026-08-10 | |
| 2023-12-31 | $2,160,564 | 19,629 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||